抗生物質耐性の100年を解明:遺伝的原因の特定(Capturing 100 years of antibiotic resistance evolution)

ad

2025-09-25 バース大学

Web要約 の発言:
バース大学、ウェルカム・サンガー研究所、英国HSAらの国際チームは、1917年以前の菌株を含む過去100年の細菌試料4万件以上のプラスミドDNAを解析し、抗菌薬耐性進化の歴史を明らかにしました。研究は、世界的な多剤耐性を引き起こすのは少数のプラスミドであること、これらは元来耐性遺伝子を持たず、抗生物質の使用拡大とともに耐性を獲得したことを示しました。進化経路として「遺伝子挿入」「他プラスミドとの融合」の2系統が主要で、融合型は種間伝達性が高いと判明。成果は将来的に耐性プラスミドを標的とした新規治療法の開発や、今後の耐性感染症流行予測に貢献すると期待されます

抗生物質耐性の100年を解明:遺伝的原因の特定(Capturing 100 years of antibiotic resistance evolution)
The team analysed the DNA from bacterial samples as far back as 1917, before antibiotics were discovered, to see how they had evolved since.

<関連情報>

抗生物質以前と以後の時代:抗菌薬耐性の歴史的広がり Pre- and postantibiotic epoch: The historical spread of antimicrobial resistance

Adrian Cazares, Wendy Figueroa, Daniel Cazares, Leandro Lima, […] , and Nicholas R. Thomson
Science  Published:25 Sep 2025
DOI:https://doi.org/10.1126/science.adr1522

Abstract

Plasmids are now the primary vectors of antimicrobial resistance, but our understanding of how human industrialisation of antibiotics influenced their evolution is limited by a paucity of data predating the antibiotic era (PAE). By investigating plasmids from clinically relevant bacteria sampled and isolated between 1917 and 1954 and comparing them to modern plasmids, we have captured over 100 years of evolution. We show that while virtually all PAE plasmids were devoid of resistance genes and most never acquired them, a minority evolved to drive the global spread of resistance to first line and last resort antibiotics in Gram-negative bacteria. Modern plasmids have evolved through complex microevolution and fusion events into a distinct group of highly recombinogenic, multi-replicon, self-transmissible plasmids that now pose the highest risk to resistance dissemination, and therefore to human health.

有機化学・薬学
ad
ad
Follow
ad
タイトルとURLをコピーしました